Research Article

Efficiently Capturing Mitochondria-Targeted Constituents with Hepatoprotective Activity from Medicinal Herbs

Table 2

LC/MS data and assignment of 15 bioactive constituents in PR extract.

No. (min)∆Pb (%, )UV (nm)[M+H]+ ([M+Na]+) ESI-MSn(+) (abundance)[M-H]-ESI-MSn(-) (abundance)Predicted formulaMeas. ()Pred. ()Diff. (ppm)DBEAssigned identification

P131.593200409.1899MS2 (409):247 (100)407.0915MS2 (407):361 (100), 362 (23), 354 (16), 283 (16), 248 (15), 108 (15), 230 (14), 219 (14), 202 (14), 154 (12), 104 (11)C23H36O6408.1502408.2597-1.5686Unidentified
P244.173220, 255367.1151MS2 (367):209 (100), 210 (10)365.2104MS2 (365):329 (100), 191 (10), 298 (10)C18H6O9366.2184366.0030-1.7316(−)-cis-(3R,4R)-3-angeloylkhellactone or (−)-cis-(3R,4R)-4-angeloylkhellactone
P349.950325367.1154MS2 (367):267 (100), 203 (16)
MS2 (345):203 (100), 204 (14), 187 (10)
MS3 (203):203 (100), 175 (27), 204 (15)
343.9714MS2 (343):99 (100), 261 (91), 203 (75), 175 (32), 262 (25), 280 (15), 243 (12), 229 (11)
MS3 (261):203 (100), 175 (76), 69 (64), 145 (53), 189 (42), 223 (22), 161 (21), 119 (21), 89 (17), 195 (11), 118 (11), 186 (11)
C12H8O12344.1154344.0040-2.999Pd-C-I
P451.160200, 325367.1143MS2 (367):267 (100), 203 (23), 204 (15), 268 (14), 367 (12)365.2106C18H6O9366.2145366.0030-1.7316(−)-cis-(3R,4R)-3-angeloylkhellactone or (−)-cis-(3R,4R)-4-angeloylkhellactone
P553.397325367.1150MS2 (367):267 (15)343.1196MS2 (343):215 (100), 99 (60), 95 (16), 69 (12), 172 (10), 151 (10)C12H8O12344.1270344.0040-2.999(+)-trans-(3S, 4R)-3-angeloylkhellactone
P658.633200, 325376.1389MS2 (376):245 (100), 227 (50), 287 (17), 246 (14)
MS2 (245):203 (84), 175 (24), 145 (20), 246 (15), 204 (13)
351.2317MS2 (351):59 (100), 277 (75), 351 (75), 352 (16), 278 (13)C17H20O8352.2133352.120013.448Unidentified
P760.897200, 255, 320369.0947MS2 (369):267 (100), 369 (30), 203 (22), 309 (19), 227 (10)
MS3 (267):143 (100), 102 (82), 161 (60), 184 (53), 267 (43), 269 (36), 145 (21), 238 (13), 91 (10)
MS2 (345):299 (100), 277 (65), 300 (22), 69 (21), 95 (16), 278 (14)C18H18O7346.1107346.094715.3010Qianhucoumarin D
aP863.003200, 325409.1261MS2 (409):245 (100), 227 (41)
MS3 (245):189 (100), 144 (77), 180 (32), 175 (32), 163 (30), 187 (24), 161 (24), 186 (20), 83 (17), 198 (11)
385.3148C21H22O7386.3178386.141010.3511Praeruptorin A
P963.300200, 325409.1261MS2 (409):245 (100), 309 (93), 227 (35), 409 (30), 83 (25), 310 (21), 246 (17)
MS3 (245):175 (48), 189 (16), 246 (16), 217 (15), 187 (14)
385.3148C21H22O7386.3178386.141010.3511Unidentified
P1068.660200, 325411.1402MS2 (411):217 (100), 175 (83), 187 (71), 92 (56), 201 (51), 83 (42), 69 (42), 53 (36)387.1149C21H24O7388.1180388.1570-4.2610Peucedanocoumarin I
P1169.150205449.1563MS2 (449):245 (100), 227 (71), 246 (17), 175 (14), 228 (13)425.3047C22H18O9426.2538426.099012.8314Unidentified
aP1269.713200449.1562MS2 (449):83 (100), 227 (21), 349 (13)425.3046C24H26O7426.2535426.099012.8314Praeruptorin B
aP1370.043200449.1658MS2 (449):83 (100), 227 (30), 55 (17), 349 (17), 327 (13)425.3046C24H26O7426.2538426.099012.8314Praeruptorin D
P1471.390200449.1572MS2 (449):409 (100)425.3050C24H26O7426.2535426.099012.8314Unidentified
aP1571.927200451.1780MS2 (451):227 (37), 327 (17), 349 (15)427.2556C24H28O7428.3917428.1890-6.9011Praeruptorin E

aCompared with standards. b was calculated using the following equation: , where and are the peak areas in the experiment and control, respectively. Data were obtained from 3 independent experiments and are expressed as .